NCT01931644 At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions Status COMPLETED Phase N/A
NCT01839656 A Study to Assess the Efficacy, Safety and Pharmacokinetics of Nusinersen (ISIS 396443) in Infants With Spinal Muscular Atrophy (SMA) Status COMPLETED Phase PHASE2
NCT01780246 An Open-label Safety and Tolerability Study of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy Who Previously Participated in ISIS 396443-CS1 (NCT01494701) Status COMPLETED Phase PHASE1
NCT01703988 An Open-label Safety, Tolerability and Dose-Range Finding Study of Multiple Doses of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy Status COMPLETED Phase PHASE1/PHASE2
NCT01671384 Valproate and Levocarnitine in Children With Spinal Muscular Atrophy Status UNKNOWN Phase PHASE3
NCT01645787 Short and Long Term Treatment With 4-AP in Ambulatory SMA Patients Status COMPLETED Phase PHASE2/PHASE3
NCT01611610 Clinical Assessment of Spinal Muscular Atrophy Type II and III (SMA Europe) Status COMPLETED Phase NA
NCT01494701 An Open-label Safety, Tolerability, and Dose-range Finding Study of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy (SMA) Status COMPLETED Phase PHASE1
NCT01166022 Clinical Trial of Exercise in Patients With Spinal Muscular Atrophy (SMA) Status COMPLETED Phase NA
NCT01033331 Evaluation of the Muscle Strength and Motor Ability in Children With Spinal Muscle Atrophy(SMA) Treated With Valproic Acid Status COMPLETED Phase N/A
NCT01028833 Effects of Power Mobility on Young Children With Severe Motor Impairments Status COMPLETED Phase PHASE2
NCT00961103 Motor Development and Orthoses in Spinal Muscular Atrophy (SMA) Status COMPLETED Phase N/A
NCT00528268 Study to Evaluate Sodium Phenylbutyrate in Pre-symptomatic Infants With Spinal Muscular Atrophy Status COMPLETED Phase PHASE1/PHASE2